Chest 1999-01-01

Degradation of histamine solutions used for bronchoprovocation.

P Marshik, S Moghaddam, I Tebbett, L Hendeles

Index: Chest 115(1) , 194-9, (1999)

Full Text: HTML

Abstract

To determine optimal storage conditions for histamine diphosphate (HDP) solutions used for bronchoprovocation.HDP was dissolved in buffered saline solution to concentrations of 0.125 to 16 mg/mL and stored in 3-mL unit dose syringes at different temperatures for varying lengths of time, with and without protection from fluorescent light.Dark freezer (-20 degrees C), dark refrigerator (4 degrees C), and laboratory counter top (20 degrees C) illuminated by fluorescent light (375 foot-candles).HDP concentrations were measured after the solutions were prepared and during storage by a high-performance liquid chromatographic assay that differentiates histamine from its break down products.All dilutions were sterile after preparation and contained 97 to 110% of the labeled amount of HDP. Solutions constantly exposed to fluorescent light (375 foot-candles) and room temperature (20 degrees C) contained only 20 to 37% of the initial concentrations after 7 days. The same dilutions stored at room temperature, but protected from light, contained 83 to 94% of the initial concentrations. Dilutions stored in the dark in a refrigerator (4 degrees C) retained 97% of the initial concentrations after 8 weeks, while dilutions stored in the dark freezer (-20 degrees C) were stable for 12 months.Exposure to fluorescent light at room temperature results in degradation of histamine solutions used for bronchoprovocation. Dilutions stored in unit dose syringes and protected from light are stable for at least 8 weeks in the refrigerator and up to 12 months frozen. Once removed from the refrigerator or freezer, the solutions should be used within 6 h or discarded.


Related Compounds

  • Histamine phosphat...

Related Articles:

Development of a UHPLC-MS/MS method for the determination of plasma histamine in various mammalian species.

2014-11-15

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 971 , 35-42, (2014)]

Validated capillary electrophoresis method for the assay of a range of basic drugs.

1995-07-01

[J. Pharm. Biomed. Anal. 13(8) , 951-7, (1995)]

Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast.

2001-01-01

[Ann. Allergy Asthma Immunol. 86(1) , 44-50, (2001)]

Validated capillary electrophoretic method for the quantitative analysis of histamine acid phosphate and/or benzalkonium chloride.

1996-11-08

[J. Chromatogr. B, Biomed. Appl. 686(1) , 111-7, (1996)]

Nasal hyperreactivity and its effect on early and late sequelae of nasal challenge with house-dust mite extract.

1993-01-01

[Allergy Proc. 14(4) , 273-81, (1993)]

More Articles...